为2型糖尿病高危患者个体化制定目标和策略：来自ACCORD及其他心血管试验的实践经验 - Suppr

Suppr

超能文献

Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.

作者信息

Riddle Matthew C, Karl Diane M

机构信息

Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

Diabetes Care. 2012 Oct;35(10):2100-7. doi: 10.2337/dc12-0650.

DOI:10.2337/dc12-0650

PMID:22996182

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3447843/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbdf/3447843/eb881897c0a3/2100fig1.jpg

相似文献

Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.为2型糖尿病高危患者个体化制定目标和策略：来自ACCORD及其他心血管试验的实践经验

Diabetes Care. 2012 Oct;35(10):2100-7. doi: 10.2337/dc12-0650.

Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials.2型糖尿病强化血糖控制与心血管疾病——我们是否应该改变糖化血红蛋白的推荐目标？对ACCORD和ADVANCE试验的评论

Pol Arch Med Wewn. 2008 Nov;118(11):619-21.

Diabetes. Insights from the extended follow-up of the ACCORD trial.糖尿病。ACCORD 试验延长随访的见解。

Nat Rev Cardiol. 2011 Jun;8(6):308-10. doi: 10.1038/nrcardio.2011.65. Epub 2011 Apr 19.

Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.糖尿病控制心血管风险行动（ACCORD）试验中强化降糖对2型糖尿病患者治疗的影响。

Circulation. 2010 Aug 24;122(8):844-6. doi: 10.1161/CIRCULATIONAHA.110.960138.

[Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials].[2型糖尿病患者的血糖控制与心血管疾病。ACCORD、ADVANCE及退伍军人糖尿病试验结果]

Rev Med Liege. 2008 Jul-Aug;63(7-8):511-8.

Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.2型糖尿病中的心血管疾病与强化血糖控制：推动实践走向基于证据的策略

Vasc Health Risk Manag. 2009;5:859-71. doi: 10.2147/vhrm.s4808. Epub 2009 Nov 2.

[Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].[2型糖尿病强化血糖控制：是真正的进展还是深度的不协调？]

Rev Med Suisse. 2008 Aug 6;4(166):1734.

Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.强化血糖控制：ACCORD、ADVANCE及VADT试验对家庭医生的启示

Can Fam Physician. 2009 Aug;55(8):803-4.

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications.糖尿病心血管风险控制行动（ACCORD）试验——临床意义

Clin Chem. 2011 Feb;57(2):261-3. doi: 10.1373/clinchem.2010.148288. Epub 2010 Oct 25.

[Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].[2型糖尿病患者强化血糖治疗：与ACCORD研究相比，ADVANCE研究中无死亡率增加的证据]

MMW Fortschr Med. 2008 Apr 24;150(17):42-4. doi: 10.1007/BF03365441.

引用本文的文献

Synergistic Impact of Glycaemic Control and Coronary Stenosis Severity on Long-Term Prognosis in Diabetes with Chronic Coronary Syndrome: A Ten-Year Retrospective Study.血糖控制与冠状动脉狭窄严重程度对慢性冠状动脉综合征糖尿病患者长期预后的协同影响：一项十年回顾性研究

Diabetes Metab Syndr Obes. 2025 Sep 3;18:3191-3201. doi: 10.2147/DMSO.S528159. eCollection 2025.

Persistent Cardiometabolic Health Gaps: Can Therapeutic Care Gaps Be Precisely Identified from Electronic Health Records.持续存在的心脏代谢健康差距：能否从电子健康记录中精确识别治疗护理差距？

Healthcare (Basel). 2021 Dec 31;10(1):70. doi: 10.3390/healthcare10010070.

HbA1c trajectory and cardiovascular outcomes: an analysis of data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study.糖化血红蛋白（HbA1c）轨迹与心血管结局：糖尿病心血管风险控制行动（ACCORD）研究数据分析

Ther Adv Chronic Dis. 2021 Jun 27;12:20406223211026391. doi: 10.1177/20406223211026391. eCollection 2021.

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment.对 ACCORD 强化血糖治疗有反应的 2 型糖尿病亚型。

Diabetes Care. 2021 Jun;44(6):1410-1418. doi: 10.2337/dc20-2700. Epub 2021 Apr 16.

Relevant patient characteristics for guiding tailored integrated diabetes primary care: a systematic review.指导定制化综合糖尿病初级保健的相关患者特征：一项系统综述

Prim Health Care Res Dev. 2018 Sep;19(5):424-447. doi: 10.1017/S146342361800004X. Epub 2018 Feb 6.

A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.一个包含体重指数、糖化血红蛋白和甘油三酯的风险评分可预测 2 型糖尿病患者未来的血糖控制情况。

Diabetes Obes Metab. 2018 Mar;20(3):681-688. doi: 10.1111/dom.13148. Epub 2017 Nov 24.

Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study.根据血糖控制水平和健康相关生活质量对糖尿病患者进行生物心理社会特征差异分析：马斯特里赫特研究。

PLoS One. 2017 Jul 27;12(7):e0182053. doi: 10.1371/journal.pone.0182053. eCollection 2017.

Profiling Patients' Healthcare Needs to Support Integrated, Person-Centered Models for Long-Term Disease Management (Profile): Research Design.剖析患者的医疗保健需求以支持长期疾病管理的综合、以患者为中心的模式（剖析项目）：研究设计

Int J Integr Care. 2016 Apr 29;16(2):1. doi: 10.5334/ijic.2208.

Diabetes: Controlling glucose levels in elderly people--benefits versus risks.糖尿病：老年人血糖水平的控制——益处与风险

Nat Rev Endocrinol. 2015 May;11(5):257-8. doi: 10.1038/nrendo.2015.23. Epub 2015 Feb 24.

Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.将英国前瞻性糖尿病研究（UKPDS）68风险方程适配于英国当代常规临床实践数据。

Pharmacoeconomics. 2015 Feb;33(2):149-61. doi: 10.1007/s40273-014-0225-z.

本文引用的文献

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理：以患者为中心的方法：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的立场声明

Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.

Standards of medical care in diabetes--2012.《糖尿病医疗护理标准——2012》

Diabetes Care. 2012 Jan;35 Suppl 1(Suppl 1):S11-63. doi: 10.2337/dc12-s011.

The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study.ACCORD 研究中频繁且未被识别的低血糖对死亡率的影响。

Diabetes Care. 2012 Feb;35(2):409-14. doi: 10.2337/dc11-0996. Epub 2011 Dec 16.

Optimal management of type 2 diabetes: the evidence.2 型糖尿病的最佳管理：证据。

Diabetes Obes Metab. 2012 Jan;14 Suppl 1:3-8. doi: 10.1111/j.1463-1326.2011.01506.x.

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.强化血糖控制对 2 型糖尿病患者的影响：随机临床试验的系统评价和试验序贯分析。

BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898.

Clinical implications of the ACCORD trial.ACCORD 试验的临床意义。

J Clin Endocrinol Metab. 2012 Jan;97(1):41-8. doi: 10.1210/jc.2011-1679. Epub 2011 Nov 2.

Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.低血糖相关死亡率与药物无关，而是与合并症相关。

Am J Med. 2011 Nov;124(11):1028-35. doi: 10.1016/j.amjmed.2011.07.011.

Death during intensive glycemic therapy of diabetes: mechanisms and implications.糖尿病强化血糖治疗期间的死亡：机制与影响

Am J Med. 2011 Nov;124(11):993-6. doi: 10.1016/j.amjmed.2011.08.008.

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.强化血糖控制对 2 型糖尿病患者脑结构和功能的影响（ACCORD MIND）：一项随机、开放标签的亚研究。

Lancet Neurol. 2011 Nov;10(11):969-77. doi: 10.1016/S1474-4422(11)70188-0. Epub 2011 Sep 28.

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.强化血糖降低治疗对 2 型糖尿病患者全因死亡率、心血管死亡和微血管事件的影响：随机对照试验的荟萃分析。

BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验